VEGFA and B-cell chronic lymphocytic leukemia: PKCβII can also be activated downstream of growth factors such as vascular endothelial growth factor (VEGF) [45], indicating that the activation status of PKCβII and thus its pro-survival function is linked to the lymphoid organ microenvironment of CLL patients.